SPOTLIGHT: S. Korea to fund anti-aging research

South Korea says it will spend $20 million over the next 10 years to fund research into new therapies to extend a person's productive life span. The country says it needs the new therapies to offset a low birthrate. Report 

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.